Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene
Open accessPublished version of a preprint
The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Abstract
Trk ( NTRK ) receptor and NTRK gene fusions are oncogenic drivers of a wide variety of tumors. Although Trk receptors are typically activated at the cell surface, signaling of constitutive active Trk and diverse intracellular NTRK fusion oncogenes is barely investigated. Here, we show that a high intracellular abundance is sufficient for neurotrophin-independent, constitutive activation of TrkB kinase domains. In HEK293 cells, constitutive active TrkB kinase and an intracellular NTRK2-fusion oncogene (SQSTM1-NTRK2) reduced actin filopodia dynamics, phosphorylated FAK, and altered the cell morphology. Atypical cellular responses could be mimicked with the intracellular kinase domain, which did not activate the Trk-associated MAPK/ERK pathway. In glioblastoma-like U87MG cells, expression of TrkB or SQSTM1-NTRK2 reduced cell motility and caused drastic changes in the transcriptome. Clinically approved Trk inhibitors or mutating Y 705 in the kinase domain, blocked the cellular effects and transcriptome changes. Atypical signaling was also seen for TrkA and TrkC. Moreover, hallmarks of atypical pTrk kinase were found in biopsies of Nestin-positive glioblastoma. Therefore, we suggest Western blot-like immunoassay screening of NTRK-related (brain) tumor biopsies to identify patients with atypical panTrk or phosphoTrk signals. Such patients could be candidates for treatment with NTRK inhibitors such as Larotrectinhib or Entrectinhib.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained TrkB activation enhances survival and growth signaling, and Trk family receptors are established oncogenic drivers when aberrantly engaged [135,136,137].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [136]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“The count output was used to identify differentially expressed genes using DESeq2 [51] version 1.24.0.”
InfluentialNIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · cited 1×
“12-bit z-stack images were processed by maximum intensity projection and adjusted for brightness and contrast using Image J software (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, https:// imagej.nih.gov/ij/) [47].”
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“7.2b with default parameters based on the RefSeq annotation version 109.20210226 for GRCh38.p13 [49].”
InfluentialCutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889 · cited 1×
“To ensure high sequence quality, Illumina reads were quality-and adapter-trimmed using Cutadapt [48] version 2.5 using a cutoff Phred score of 20 in the NextSeq mode, and reads without any remaining bases were discarded (command line parameters: --nextseq-trim = 20 -m 1 -a…”
InfluentialfeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
Raudvere, U., Kolberg, L., Kuzmin, I., Arak, T., Adler, P., Peterson, H., & Vilo, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz369 · Cited by 5,045
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856 · cited 2×
“Doxycycline-inducible lentiviral expression of TrkB constructs was performed using a vector backbone based on pCW [41].”
Cited by
Lei, P., & Li, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1666343 · Cited by 5
Федотчева, Т. А., & Shimanovsky, N. L. (2025) · Medical Sciences · doi:10.3390/medsci14010015 · Cited by 6
Rahm, K. K., Kinghorn, B. S., Moody, M. J., Stone, B. C., Strong, K., Kim, B. S., Chang, Y. J., Sleight, S., Nitz, A. A., Hansen, D. V., et al. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1681811 · Cited by 5
“…the creation of two classifiers, a primary cell classifier and cell-line classifier, we tested RNA-seq data generated from many different studies (Gupta et al., 2024; Schirmer et al., 2019; Masuda et al., 2019; Quiroga et al., 2022; Armanville et al., 2025; Baek and Yoo, 2021; Baek et al.,…”
Jastrząb, P., Car, H., & Wielgat, P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117921 · Cited by 4
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Gupta, R., Dittmeier, M., Wohlleben, G., Nickl, V., Bischler, T., Luzak, V., Wegat, V., Doll, D., Sodmann, A., Bady, E., Langlhofer, G., Wachter, B., Havlicek, S., Gupta, J., Horn, E., Lüningschrör, P., Villmann, C., Polat, B., Wischhusen, J., Monoranu, C. M., Kuper, J., & Blum, R.
- Affiliations
- Universitätsklinikum Würzburg (DE)
- University of Würzburg (DE)
- Fraunhofer Institute for Interfacial Engineering and Biotechnology (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Blum, Robert
- ORCID
- Venue
- Cancer Gene Therapy
- Published
- 2024-07-22
- Volume
- 31
- Issue
- 9
- Pages
- 1357-1379
- ISSN
- 0929-1903 (ISSN-L)
- 1476-5500
- PMC
- PMC11405271
- OpenAlex
- W4400896163
- Cited by
- 7
- References
- 82
- Citations by year
- 2026: 2 · 2025: 5
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cancer Gene Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (project-ID: 194101929 (BL567/3-2), project ID: 326998133; CRC TRR225 (B01))
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (project Z-6, B-450)
- Evangelisches Studienwerk Villigst
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- TrkB, NTRK2, constitutive kinase activation, focal adhesion kinase phosphorylation, cell morphology, cell motility, glioblastoma, TrkA, TrkC, TRK inhibitors, larotrectinib, entrectinib, transcriptome changes
- MeSH terms
- Cell Movement, Glioblastoma, Humans, Membrane Glycoproteins, Signal Transduction, Oncogene Proteins, Fusion, Receptor, trkB, Cell Line, Tumor, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene. https://app.cochat.ai/papers/10.1038/s41417-024-00809-0
- The paper
- Gupta, R., Dittmeier, M., Wohlleben, G., Nickl, V., Bischler, T., Luzak, V., Wegat, V., Doll, D., Sodmann, A., Bady, E., Langlhofer, G., Wachter, B., Havlicek, S., Gupta, J., Horn, E., Lüningschrör, P., Villmann, C., Polat, B., Wischhusen, J., . . . Blum, R. (2024). Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene. Cancer Gene Therapy. https://doi.org/10.1038/s41417-024-00809-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.